Eli Lilly launches weight-loss drug Mounjaro in India at competitive pricing
US pharmaceutical giant Eli Lilly has launched its blockbuster diabetes and weight-loss drug, Mounjaro, in India following ...
CNBCTV1831m
Eli Lilly’s weight loss and diabetes drug now in India – check details
Eli Lilly has launched its blockbuster diabetes and weight-loss drug Mounjaro in India following approval from the country’s drug regulator.
5 Reasons It's Not Too Late to Buy Eli Lilly Stock
Eli Lilly (NYSE: LLY) has been around for almost 150 years, finding ways to innovate and grow. The next largest healthcare ...
Popular anti-diabetes, weight-loss drug Mounjaro launched in India, 2.5 mg vial priced at Rs 3,500
Mounjaro, chemically known as tirzepatide, is currently sold in the UK and Europe under the same brand name for both diabetes ...